Publication | Open Access
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
21
Citations
22
References
2022
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1